PRISMA (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "PRISMA" in Japanese language version.

Last modified: 08:23:37, 17 January 2026 (UTC)

Ref.Un. Ref.Website

Global rank Japanese rank

2219nih.gov

5^th place

11^th place

1413doi.org

2^nd place

3^rd place

99prisma-statement.org

low place

doi.org (Global: 2^nd place; Japanese: 3^rd place)

Liberati, A; Altman, DG; Tetzlaff, J; Mulrow, C; Gøtzsche, PC; Ioannidis, JPA; Clarke, M; Devereaux, PJ et al. (2009). “The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration”. PLOS Medicine 6 (7): e1000100. doi:10.1371/journal.pmed.1000100. PMC 2707010. PMID 19621070.
Mulrow, CD (1987). “The Medical Review Article: State of the Science”. Annals of Internal Medicine 106 (3): 485–488. doi:10.7326/0003-4819-106-3-485. PMID 3813259.
Sacks, HS; Berrier, J; Reitman, D; Ancona-Berk, VA; Chalmers, TC (1987). “Meta-Analyses of Randomized Controlled Trials”. New England Journal of Medicine 316 (8): 450–455. doi:10.1056/NEJM198702193160806. PMID 3807986.
Moher, D; Cook, DJ; Eastwood, S; Olkin, I; Rennie, D; Stroup, DF (1999). “Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement”. The Lancet 354 (9193): 1896–1900. doi:10.1016/S0140-6736(99)04149-5. PMID 10584742.
Bhaumik, S; Lassi, Z (2017). “Vitamin D as an adjunct for acute community-acquired pneumonia among infants and children: systematic review and meta-analysis”. WikiJournal of Medicine 4 (1). doi:10.15347/wjm/2017.005.
Moher, D; Liberati, A; Tetzlaff, J; Altman, DG (2009). “Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement”. PLOS Medicine 6 (7): e1000097. doi:10.1371/journal.pmed.1000097. PMC 2707599. PMID 19621072.
Moher, D; Liberati, A; Tetzlaff, J; Altman, DG (2009). “Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement”. Annals of Internal Medicine 151 (4): 264–269. doi:10.7326/0003-4819-151-4-200908180-00135. PMC 3090117. PMID 21603045.
Moher, D; Liberati, A; Tetzlaff, J; Altman, DG (2009). “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement”. BMJ 339: b2535. doi:10.1136/bmj.b2535.
Moher, D; Liberati, A; Tetzlaff, J; Altman, DG (2009). “Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement”. Journal of Clinical Epidemiology 62 (10): 1006–1012. doi:10.1016/j.jclinepi.2009.06.005. PMID 19631508.
Moher, D; Liberati, A; Tetzlaff, J; Altman, DG (2010). “Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement”. International Journal of Surgery 8 (5): 336–341. doi:10.1016/j.ijsu.2010.02.007. PMID 20171303.
Tao, KM; Li, XQ; Zhou, QH; Moher, D; Ling, CQ; Yu, WF; Phillips, RS (2011). “From QUOROM to PRISMA: A Survey of High-Impact Medical Journals' Instructions to Authors and a Review of Systematic Reviews in Anesthesia Literature”. PLOS ONE 6 (11): e27611. doi:10.1371/journal.pone.0027611. PMC 3217994. PMID 22110690.
Tricco AC (2018). “PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation”. Ann Intern Med 169 (7): 467-73. doi:10.7326/M18-0850. PMID 30178033.
“PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews”. Syst Rev 10 (1): 39. (2021 Jan 26). doi:10.1186/s13643-020-01542-z. PMID 33499930.

nih.gov (Global: 5^th place; Japanese: 11^th place)

pubmed.ncbi.nlm.nih.gov

Liberati, A; Altman, DG; Tetzlaff, J; Mulrow, C; Gøtzsche, PC; Ioannidis, JPA; Clarke, M; Devereaux, PJ et al. (2009). “The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration”. PLOS Medicine 6 (7): e1000100. doi:10.1371/journal.pmed.1000100. PMC 2707010. PMID 19621070.
Mulrow, CD (1987). “The Medical Review Article: State of the Science”. Annals of Internal Medicine 106 (3): 485–488. doi:10.7326/0003-4819-106-3-485. PMID 3813259.
Sacks, HS; Berrier, J; Reitman, D; Ancona-Berk, VA; Chalmers, TC (1987). “Meta-Analyses of Randomized Controlled Trials”. New England Journal of Medicine 316 (8): 450–455. doi:10.1056/NEJM198702193160806. PMID 3807986.
Moher, D; Cook, DJ; Eastwood, S; Olkin, I; Rennie, D; Stroup, DF (1999). “Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement”. The Lancet 354 (9193): 1896–1900. doi:10.1016/S0140-6736(99)04149-5. PMID 10584742.
Moher, D; Liberati, A; Tetzlaff, J; Altman, DG (2009). “Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement”. PLOS Medicine 6 (7): e1000097. doi:10.1371/journal.pmed.1000097. PMC 2707599. PMID 19621072.
Moher, D; Liberati, A; Tetzlaff, J; Altman, DG (2009). “Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement”. Annals of Internal Medicine 151 (4): 264–269. doi:10.7326/0003-4819-151-4-200908180-00135. PMC 3090117. PMID 21603045.
Moher, D; Liberati, A; Tetzlaff, J; Altman, DG (2009). “Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement”. Journal of Clinical Epidemiology 62 (10): 1006–1012. doi:10.1016/j.jclinepi.2009.06.005. PMID 19631508.
Moher, D; Liberati, A; Tetzlaff, J; Altman, DG (2010). “Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement”. International Journal of Surgery 8 (5): 336–341. doi:10.1016/j.ijsu.2010.02.007. PMID 20171303.
Tao, KM; Li, XQ; Zhou, QH; Moher, D; Ling, CQ; Yu, WF; Phillips, RS (2011). “From QUOROM to PRISMA: A Survey of High-Impact Medical Journals' Instructions to Authors and a Review of Systematic Reviews in Anesthesia Literature”. PLOS ONE 6 (11): e27611. doi:10.1371/journal.pone.0027611. PMC 3217994. PMID 22110690.
Tricco AC (2018). “PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation”. Ann Intern Med 169 (7): 467-73. doi:10.7326/M18-0850. PMID 30178033.
“PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews”. Syst Rev 10 (1): 39. (2021 Jan 26). doi:10.1186/s13643-020-01542-z. PMID 33499930.

pmc.ncbi.nlm.nih.gov

Liberati, A; Altman, DG; Tetzlaff, J; Mulrow, C; Gøtzsche, PC; Ioannidis, JPA; Clarke, M; Devereaux, PJ et al. (2009). “The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration”. PLOS Medicine 6 (7): e1000100. doi:10.1371/journal.pmed.1000100. PMC 2707010. PMID 19621070.
Moher, D; Liberati, A; Tetzlaff, J; Altman, DG (2009). “Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement”. PLOS Medicine 6 (7): e1000097. doi:10.1371/journal.pmed.1000097. PMC 2707599. PMID 19621072.
Moher, D; Liberati, A; Tetzlaff, J; Altman, DG (2009). “Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement”. Annals of Internal Medicine 151 (4): 264–269. doi:10.7326/0003-4819-151-4-200908180-00135. PMC 3090117. PMID 21603045.
Tao, KM; Li, XQ; Zhou, QH; Moher, D; Ling, CQ; Yu, WF; Phillips, RS (2011). “From QUOROM to PRISMA: A Survey of High-Impact Medical Journals' Instructions to Authors and a Review of Systematic Reviews in Anesthesia Literature”. PLOS ONE 6 (11): e27611. doi:10.1371/journal.pone.0027611. PMC 3217994. PMID 22110690.

ncbi.nlm.nih.gov

Liberati, A; Altman, DG; Tetzlaff, J; Mulrow, C; Gøtzsche, PC; Ioannidis, JPA; Clarke, M; Devereaux, PJ et al. (2009). “The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration”. PLOS Medicine 6 (7): e1000100. doi:10.1371/journal.pmed.1000100. PMC 2707010. PMID 19621070.
Moher, D; Liberati, A; Tetzlaff, J; Altman, DG (2009). “Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement”. PLOS Medicine 6 (7): e1000097. doi:10.1371/journal.pmed.1000097. PMC 2707599. PMID 19621072.
Moher, D; Liberati, A; Tetzlaff, J; Altman, DG (2009). “Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement”. Annals of Internal Medicine 151 (4): 264–269. doi:10.7326/0003-4819-151-4-200908180-00135. PMC 3090117. PMID 21603045.
Tao, KM; Li, XQ; Zhou, QH; Moher, D; Ling, CQ; Yu, WF; Phillips, RS (2011). “From QUOROM to PRISMA: A Survey of High-Impact Medical Journals' Instructions to Authors and a Review of Systematic Reviews in Anesthesia Literature”. PLOS ONE 6 (11): e27611. doi:10.1371/journal.pone.0027611. PMC 3217994. PMID 22110690.

prisma-statement.org (Global: low place; Japanese: low place)

the PRISMA statement
“PRISMA”. www.prisma-statement.org/News. 2018年12月12日閲覧。
PRISMA Endorsers. http://www.prisma-statement.org/Endorsement/PRISMAEndorsers
“PRISMA 2020 for Abstracts”. PRISMA. 2022年3月19日閲覧。
“PRISMA for Individual Patient Data systematic reviews (PRISMA-IPD)”. PRISMA. 2022年3月19日閲覧。
“PRISMA for Network Meta-Analyses (PRISMA-NMA)”. PRISMA. 2022年3月19日閲覧。
“PRISMA for systematic review protocols (PRISMA-P)”. PRISMA. 2022年3月19日閲覧。
“PRISMA for Scoping Reviews”. PRISMA. 2022年3月19日閲覧。
“PRISMA for Searching”. PRISMA. 2022年3月19日閲覧。